Alogliptin
NDC 71610-300, Alogliptin, tablet, film coated, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-300
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022271
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALOGLIPTIN BENZOATE25 mg/1
Pharmacologic classes
Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-300-09 | 71610030009 | 9000 TABLET, FILM COATED in 1 BOTTLE (71610-300-09) |
| 71610-300-18 | 71610030018 | 3000 TABLET, FILM COATED in 1 BOTTLE (71610-300-18) |
| 71610-300-60 | 71610030060 | 90 TABLET, FILM COATED in 1 BOTTLE (71610-300-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4b007011-547a-498e-b8f6-34ea4ea00eb4
Use it
Look up 71610-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.